These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

798 related items for PubMed ID: 29581064

  • 1. Molecular signatures of medullary thyroid carcinoma by matrix-assisted laser desorption/ionisation mass spectrometry imaging.
    Smith A, Galli M, Piga I, Denti V, Stella M, Chinello C, Fusco N, Leni D, Manzoni M, Roversi G, Garancini M, Pincelli AI, Cimino V, Capitoli G, Magni F, Pagni F.
    J Proteomics; 2019 Jan 16; 191():114-123. PubMed ID: 29581064
    [Abstract] [Full Text] [Related]

  • 2. Histology-guided proteomic analysis to investigate the molecular profiles of clear cell Renal Cell Carcinoma grades.
    Stella M, Chinello C, Cazzaniga A, Smith A, Galli M, Piga I, Grasso A, Grasso M, Del Puppo M, Varallo M, Bovo G, Magni F.
    J Proteomics; 2019 Jan 16; 191():38-47. PubMed ID: 29698802
    [Abstract] [Full Text] [Related]

  • 3. Proteomics for the diagnosis of thyroid lesions: preliminary report.
    Pagni F, Mainini V, Garancini M, Bono F, Vanzati A, Giardini V, Scardilli M, Goffredo P, Smith AJ, Galli M, De Sio G, Magni F.
    Cytopathology; 2015 Oct 16; 26(5):318-24. PubMed ID: 25040579
    [Abstract] [Full Text] [Related]

  • 4. Peptide Profile Differences of Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features, Encapsulated Follicular Variant, and Classical Papillary Thyroid Carcinoma: An Application of Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry Imaging.
    Ucal Y, Tokat F, Duren M, Ince U, Ozpinar A.
    Thyroid; 2019 Aug 16; 29(8):1125-1137. PubMed ID: 31064269
    [Abstract] [Full Text] [Related]

  • 5. Analytical Performance of a Gene Expression Classifier for Medullary Thyroid Carcinoma.
    Pankratz DG, Hu Z, Kim SY, Monroe RJ, Wong MG, Traweek ST, Kloos RT, Walsh PS, Kennedy GC.
    Thyroid; 2016 Nov 16; 26(11):1573-1580. PubMed ID: 27605259
    [Abstract] [Full Text] [Related]

  • 6. Quantitative Proteomics Analysis of Sporadic Medullary Thyroid Cancer Reveals FN1 as a Potential Novel Candidate Prognostic Biomarker.
    Zhan S, Li J, Wang T, Ge W.
    Oncologist; 2018 Dec 16; 23(12):1415-1425. PubMed ID: 29739896
    [Abstract] [Full Text] [Related]

  • 7. Detergent addition to tryptic digests and ion mobility separation prior to MS/MS improves peptide yield and protein identification for in situ proteomic investigation of frozen and formalin-fixed paraffin-embedded adenocarcinoma tissue sections.
    Djidja MC, Francese S, Loadman PM, Sutton CW, Scriven P, Claude E, Snel MF, Franck J, Salzet M, Clench MR.
    Proteomics; 2009 May 16; 9(10):2750-63. PubMed ID: 19405023
    [Abstract] [Full Text] [Related]

  • 8. Tissue imaging and serum lipidomic profiling for screening potential biomarkers of thyroid tumors by matrix-assisted laser desorption/ionization-Fourier transform ion cyclotron resonance mass spectrometry.
    Guo S, Qiu L, Wang Y, Qin X, Liu H, He M, Zhang Y, Li Z, Chen X.
    Anal Bioanal Chem; 2014 Jul 16; 406(18):4357-70. PubMed ID: 24842401
    [Abstract] [Full Text] [Related]

  • 9. Diagnosis and pathologic characteristics of medullary thyroid carcinoma-review of current guidelines.
    Thomas CM, Asa SL, Ezzat S, Sawka AM, Goldstein D.
    Curr Oncol; 2019 Oct 16; 26(5):338-344. PubMed ID: 31708652
    [Abstract] [Full Text] [Related]

  • 10. Molecular profiles of thyroid cancer subtypes: Classification based on features of tissue revealed by mass spectrometry imaging.
    Pietrowska M, Diehl HC, Mrukwa G, Kalinowska-Herok M, Gawin M, Chekan M, Elm J, Drazek G, Krawczyk A, Lange D, Meyer HE, Polanska J, Henkel C, Widlak P.
    Biochim Biophys Acta Proteins Proteom; 2017 Jul 16; 1865(7):837-845. PubMed ID: 27760391
    [Abstract] [Full Text] [Related]

  • 11. Diagnostic value of selected biochemical markers in the detection of recurrence of medullary thyroid cancer - comparison of calcitonin, procalcitonin, chromogranin A, and carcinoembryonic antigen.
    Woliński K, Kaznowski J, Klimowicz A, Maciejewski A, Łapińska-Cwojdzińska D, Gurgul E, Car AD, Fichna M, Gut P, Gryczyńska M, Ruchała M.
    Endokrynol Pol; 2017 Jul 16; 68(4):434-437. PubMed ID: 28585679
    [Abstract] [Full Text] [Related]

  • 12. Classification of Thyroid Tumors Based on Mass Spectrometry Imaging of Tissue Microarrays; a Single-Pixel Approach.
    Kurczyk A, Gawin M, Chekan M, Wilk A, Łakomiec K, Mrukwa G, Frątczak K, Polanska J, Fujarewicz K, Pietrowska M, Widlak P.
    Int J Mol Sci; 2020 Aug 31; 21(17):. PubMed ID: 32878024
    [Abstract] [Full Text] [Related]

  • 13. Proteomics in thyroid cytopathology: Relevance of MALDI-imaging in distinguishing malignant from benign lesions.
    Pagni F, De Sio G, Garancini M, Scardilli M, Chinello C, Smith AJ, Bono F, Leni D, Magni F.
    Proteomics; 2016 Jun 31; 16(11-12):1775-84. PubMed ID: 27029406
    [Abstract] [Full Text] [Related]

  • 14. High CEA levels in a case of resected colorectal cancer: delayed diagnosis of metachronous medullary thyroid cancer.
    Chen SW, Chen YK.
    World J Surg Oncol; 2017 Dec 29; 15(1):230. PubMed ID: 29284496
    [Abstract] [Full Text] [Related]

  • 15. Ex vivo thyroid fine needle aspirations as an alternative for MALDI-MSI proteomic investigation: intra-patient comparison.
    Piga I, Capitoli G, Clerici F, Mahajneh A, Brambilla V, Smith A, Leni D, L'Imperio V, Galimberti S, Pagni F, Magni F.
    Anal Bioanal Chem; 2021 Feb 29; 413(5):1259-1266. PubMed ID: 33277997
    [Abstract] [Full Text] [Related]

  • 16. Analysis of Amyloid in Medullary Thyroid Carcinoma by Mass Spectrometry-Based Proteomic Analysis.
    Erickson LA, Vrana JA, Theis J, Rivera M, Lloyd RV, McPhail E, Zhang J.
    Endocr Pathol; 2015 Dec 29; 26(4):291-5. PubMed ID: 26304852
    [Abstract] [Full Text] [Related]

  • 17. MALDI-MSI Analysis of Cytological Smears: The Study of Thyroid Cancer.
    Mosele N, Smith A, Galli M, Pagni F, Magni F.
    Methods Mol Biol; 2017 Dec 29; 1618():37-47. PubMed ID: 28523498
    [Abstract] [Full Text] [Related]

  • 18. Polysialic acid of the neural cell adhesion molecule in the human thyroid: a marker for medullary thyroid carcinoma and primary C-cell hyperplasia. An immunohistochemical study on 79 thyroid lesions.
    Komminoth P, Roth J, Saremaslani P, Matias-Guiu X, Wolfe HJ, Heitz PU.
    Am J Surg Pathol; 1994 Apr 29; 18(4):399-411. PubMed ID: 8141431
    [Abstract] [Full Text] [Related]

  • 19. Identification of Proteomic Markers in Head and Neck Cancer Using MALDI-MS Imaging, LC-MS/MS, and Immunohistochemistry.
    Hoffmann F, Umbreit C, Krüger T, Pelzel D, Ernst G, Kniemeyer O, Guntinas-Lichius O, Berndt A, von Eggeling F.
    Proteomics Clin Appl; 2019 Jan 29; 13(1):e1700173. PubMed ID: 30411850
    [Abstract] [Full Text] [Related]

  • 20. Fine-needle aspiration cytology for medullary thyroid carcinoma: a single institutional experience in Japan.
    Suzuki A, Hirokawa M, Takada N, Higuchi M, Ito A, Yamao N, Hayashi T, Kuma S, Miyauchi A.
    Endocr J; 2017 Nov 29; 64(11):1099-1104. PubMed ID: 28883261
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.